CIK 0001563665
- Non-accelerated filer
- Smaller reporting company
Harvard Apparatus Regenerative Technology, Inc.
Sign in to watch- Ticker
- HRGN
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455210462
- Phone
- +1 774-233-7300
- Business address
- 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
- Former names
- Biostage, Inc.
- Open-market buys, last 90 days
- $394,459
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$394,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-14 | Robinson Thomas H Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-03-14 | Robinson Thomas H Director | Grant or award · Restricted Stock Units | +18,250 | 18,250 | ||
| 2017-03-14 | McNaughton Thomas Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,750 | 150,750 | ||
| 2017-03-14 | McNaughton Thomas Chief Financial Officer | Grant or award · Restricted Stock Units | +74,250 | 74,250 | ||
| 2017-03-14 | LaFrancesca Saverio | Grant or award · Stock Option (right to buy) | +217,750 | 217,750 | ||
| 2017-03-14 | LaFrancesca Saverio | Grant or award · Restricted Stock Units | +107,250 | 107,250 | ||
| 2017-03-14 | KENNEDY JOHN F Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-03-14 | KENNEDY JOHN F Director | Grant or award · Restricted Stock Units | +18,250 | 18,250 | ||
| 2017-03-14 | Canepa John J Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-03-14 | Canepa John J Director | Grant or award · Restricted Stock Units | +18,250 | 18,250 | ||
| 2017-03-14 | McGorry James Joseph Chief Executive Officer | Grant or award · Stock Option (right to buy) | +268,000 | 268,000 | ||
| 2017-03-14 | McGorry James Joseph Chief Executive Officer | Grant or award · Restricted Stock Units | +132,000 | 132,000 | ||
| 2017-03-14 | McKee Blaine H. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-03-14 | McKee Blaine H. Director | Grant or award · Restricted Stock Units | +18,250 | 18,250 | ||
| 2016-10-12 | DerSimonian Harout Chief Scientific Officer | Purchase | +10,000 | $0.91 | $9K | 10,000 |
| 2016-08-26 | KENNEDY JOHN F Director | Purchase | +16,182 | $0.93 | $15K | 58,406 |
| 2016-08-25 | McGorry James Joseph President and CEO | Purchase | +25,000 | $0.96 | $24K | 126,300 |
| 2016-06-21 | McGorry James Joseph President and CEO | Purchase | +20,000 | $1.07 | $21K | 101,300 |
| 2016-06-13 | Robinson Thomas H Director | Purchase | +32,000 | $1.17 | $37K | 50,000 |
| 2016-05-25 | Canepa John J Director | Purchase | +17,241 | $1.46 | $25K | 17,241 |
Page 12 of 18 · 345 trades